Aneusral en es it fr

Aneusral Brand names, Aneusral Analogs

Aneusral Brand Names Mixture

  • No information avaliable

Aneusral Chemical_Formula


Aneusral RX_link

No information avaliable

Aneusral fda sheet

Aneusral msds (material safety sheet)

Aneusral Synthesis Reference

No information avaliable

Aneusral Molecular Weight

309.469 g/mol

Aneusral Melting Point

< 25 oC

Aneusral H2O Solubility

Soluble as HCl salt

Aneusral State


Aneusral LogP


Aneusral Dosage Forms

Tablets (oral, 1 mg)

Aneusral Indication

Used for the symptomatic treatment of parkinsonism.

Aneusral Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Aneusral Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Aneusral side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Aneusral Patient Information

Aneusral Organisms Affected

Humans and other mammals